The global market for Telmisartan API is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Telmisartan API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Telmisartan API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Telmisartan API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Telmisartan API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Telmisartan API players cover Rundu Pharma, Jiangxi Synergy Pharmaceutical, Apeloa Pharmaceutical, Tianyu Pharmaceutical and Zhejiang Kinglyuan Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Telmisartan API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Telmisartan API market, with both quantitative and qualitative data, to help readers understand how the Telmisartan API market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Tons.
Market Segmentation:
The study segments the Telmisartan API market and forecasts the market size by Type (Purity ? 99% and Purity ? 99.5%,), by Application (Tablet, Capsule and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Purity ? 99%
Purity ? 99.5%
Segmentation by application
Tablet
Capsule
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Rundu Pharma
Jiangxi Synergy Pharmaceutical
Apeloa Pharmaceutical
Tianyu Pharmaceutical
Zhejiang Kinglyuan Pharmaceutical
Weightech (Hunan) Pharmaceutical
Liu He Pharmaceutical
Verdant Life Sciences
SMILAX
Cipla
Atom Pharma
Aalidhra Pharmachem
Dr. Reddy's Laboratories
InterQuim
RL Fine Chem
Chapter Introduction
Chapter 1: Scope of Telmisartan API, Research Methodology, etc.
Chapter 2: Executive Summary, global Telmisartan API market size (sales and revenue) and CAGR, Telmisartan API market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Telmisartan API sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Telmisartan API sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Telmisartan API market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Rundu Pharma, Jiangxi Synergy Pharmaceutical, Apeloa Pharmaceutical, Tianyu Pharmaceutical, Zhejiang Kinglyuan Pharmaceutical, Weightech (Hunan) Pharmaceutical, Liu He Pharmaceutical, Verdant Life Sciences and SMILAX, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Telmisartan API Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Telmisartan API by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Telmisartan API by Country/Region, 2017, 2022 & 2028
2.2 Telmisartan API Segment by Type
2.2.1 Purity ? 99%
2.2.2 Purity ? 99.5%
2.3 Telmisartan API Sales by Type
2.3.1 Global Telmisartan API Sales Market Share by Type (2017-2022)
2.3.2 Global Telmisartan API Revenue and Market Share by Type (2017-2022)
2.3.3 Global Telmisartan API Sale Price by Type (2017-2022)
2.4 Telmisartan API Segment by Application
2.4.1 Tablet
2.4.2 Capsule
2.4.3 Other
2.5 Telmisartan API Sales by Application
2.5.1 Global Telmisartan API Sale Market Share by Application (2017-2022)
2.5.2 Global Telmisartan API Revenue and Market Share by Application (2017-2022)
2.5.3 Global Telmisartan API Sale Price by Application (2017-2022)
3 Global Telmisartan API by Company
3.1 Global Telmisartan API Breakdown Data by Company
3.1.1 Global Telmisartan API Annual Sales by Company (2020-2022)
3.1.2 Global Telmisartan API Sales Market Share by Company (2020-2022)
3.2 Global Telmisartan API Annual Revenue by Company (2020-2022)
3.2.1 Global Telmisartan API Revenue by Company (2020-2022)
3.2.2 Global Telmisartan API Revenue Market Share by Company (2020-2022)
3.3 Global Telmisartan API Sale Price by Company
3.4 Key Manufacturers Telmisartan API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Telmisartan API Product Location Distribution
3.4.2 Players Telmisartan API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Telmisartan API by Geographic Region
4.1 World Historic Telmisartan API Market Size by Geographic Region (2017-2022)
4.1.1 Global Telmisartan API Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Telmisartan API Annual Revenue by Geographic Region
4.2 World Historic Telmisartan API Market Size by Country/Region (2017-2022)
4.2.1 Global Telmisartan API Annual Sales by Country/Region (2017-2022)
4.2.2 Global Telmisartan API Annual Revenue by Country/Region
4.3 Americas Telmisartan API Sales Growth
4.4 APAC Telmisartan API Sales Growth
4.5 Europe Telmisartan API Sales Growth
4.6 Middle East & Africa Telmisartan API Sales Growth
5 Americas
5.1 Americas Telmisartan API Sales by Country
5.1.1 Americas Telmisartan API Sales by Country (2017-2022)
5.1.2 Americas Telmisartan API Revenue by Country (2017-2022)
5.2 Americas Telmisartan API Sales by Type
5.3 Americas Telmisartan API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Telmisartan API Sales by Region
6.1.1 APAC Telmisartan API Sales by Region (2017-2022)
6.1.2 APAC Telmisartan API Revenue by Region (2017-2022)
6.2 APAC Telmisartan API Sales by Type
6.3 APAC Telmisartan API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Telmisartan API by Country
7.1.1 Europe Telmisartan API Sales by Country (2017-2022)
7.1.2 Europe Telmisartan API Revenue by Country (2017-2022)
7.2 Europe Telmisartan API Sales by Type
7.3 Europe Telmisartan API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Telmisartan API by Country
8.1.1 Middle East & Africa Telmisartan API Sales by Country (2017-2022)
8.1.2 Middle East & Africa Telmisartan API Revenue by Country (2017-2022)
8.2 Middle East & Africa Telmisartan API Sales by Type
8.3 Middle East & Africa Telmisartan API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Telmisartan API
10.3 Manufacturing Process Analysis of Telmisartan API
10.4 Industry Chain Structure of Telmisartan API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Telmisartan API Distributors
11.3 Telmisartan API Customer
12 World Forecast Review for Telmisartan API by Geographic Region
12.1 Global Telmisartan API Market Size Forecast by Region
12.1.1 Global Telmisartan API Forecast by Region (2023-2028)
12.1.2 Global Telmisartan API Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Telmisartan API Forecast by Type
12.7 Global Telmisartan API Forecast by Application
13 Key Players Analysis
13.1 Rundu Pharma
13.1.1 Rundu Pharma Company Information
13.1.2 Rundu Pharma Telmisartan API Product Offered
13.1.3 Rundu Pharma Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Rundu Pharma Main Business Overview
13.1.5 Rundu Pharma Latest Developments
13.2 Jiangxi Synergy Pharmaceutical
13.2.1 Jiangxi Synergy Pharmaceutical Company Information
13.2.2 Jiangxi Synergy Pharmaceutical Telmisartan API Product Offered
13.2.3 Jiangxi Synergy Pharmaceutical Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Jiangxi Synergy Pharmaceutical Main Business Overview
13.2.5 Jiangxi Synergy Pharmaceutical Latest Developments
13.3 Apeloa Pharmaceutical
13.3.1 Apeloa Pharmaceutical Company Information
13.3.2 Apeloa Pharmaceutical Telmisartan API Product Offered
13.3.3 Apeloa Pharmaceutical Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Apeloa Pharmaceutical Main Business Overview
13.3.5 Apeloa Pharmaceutical Latest Developments
13.4 Tianyu Pharmaceutical
13.4.1 Tianyu Pharmaceutical Company Information
13.4.2 Tianyu Pharmaceutical Telmisartan API Product Offered
13.4.3 Tianyu Pharmaceutical Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Tianyu Pharmaceutical Main Business Overview
13.4.5 Tianyu Pharmaceutical Latest Developments
13.5 Zhejiang Kinglyuan Pharmaceutical
13.5.1 Zhejiang Kinglyuan Pharmaceutical Company Information
13.5.2 Zhejiang Kinglyuan Pharmaceutical Telmisartan API Product Offered
13.5.3 Zhejiang Kinglyuan Pharmaceutical Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Zhejiang Kinglyuan Pharmaceutical Main Business Overview
13.5.5 Zhejiang Kinglyuan Pharmaceutical Latest Developments
13.6 Weightech (Hunan) Pharmaceutical
13.6.1 Weightech (Hunan) Pharmaceutical Company Information
13.6.2 Weightech (Hunan) Pharmaceutical Telmisartan API Product Offered
13.6.3 Weightech (Hunan) Pharmaceutical Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Weightech (Hunan) Pharmaceutical Main Business Overview
13.6.5 Weightech (Hunan) Pharmaceutical Latest Developments
13.7 Liu He Pharmaceutical
13.7.1 Liu He Pharmaceutical Company Information
13.7.2 Liu He Pharmaceutical Telmisartan API Product Offered
13.7.3 Liu He Pharmaceutical Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Liu He Pharmaceutical Main Business Overview
13.7.5 Liu He Pharmaceutical Latest Developments
13.8 Verdant Life Sciences
13.8.1 Verdant Life Sciences Company Information
13.8.2 Verdant Life Sciences Telmisartan API Product Offered
13.8.3 Verdant Life Sciences Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Verdant Life Sciences Main Business Overview
13.8.5 Verdant Life Sciences Latest Developments
13.9 SMILAX
13.9.1 SMILAX Company Information
13.9.2 SMILAX Telmisartan API Product Offered
13.9.3 SMILAX Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 SMILAX Main Business Overview
13.9.5 SMILAX Latest Developments
13.10 Cipla
13.10.1 Cipla Company Information
13.10.2 Cipla Telmisartan API Product Offered
13.10.3 Cipla Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Cipla Main Business Overview
13.10.5 Cipla Latest Developments
13.11 Atom Pharma
13.11.1 Atom Pharma Company Information
13.11.2 Atom Pharma Telmisartan API Product Offered
13.11.3 Atom Pharma Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Atom Pharma Main Business Overview
13.11.5 Atom Pharma Latest Developments
13.12 Aalidhra Pharmachem
13.12.1 Aalidhra Pharmachem Company Information
13.12.2 Aalidhra Pharmachem Telmisartan API Product Offered
13.12.3 Aalidhra Pharmachem Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Aalidhra Pharmachem Main Business Overview
13.12.5 Aalidhra Pharmachem Latest Developments
13.13 Dr. Reddy's Laboratories
13.13.1 Dr. Reddy's Laboratories Company Information
13.13.2 Dr. Reddy's Laboratories Telmisartan API Product Offered
13.13.3 Dr. Reddy's Laboratories Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Dr. Reddy's Laboratories Main Business Overview
13.13.5 Dr. Reddy's Laboratories Latest Developments
13.14 InterQuim
13.14.1 InterQuim Company Information
13.14.2 InterQuim Telmisartan API Product Offered
13.14.3 InterQuim Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 InterQuim Main Business Overview
13.14.5 InterQuim Latest Developments
13.15 RL Fine Chem
13.15.1 RL Fine Chem Company Information
13.15.2 RL Fine Chem Telmisartan API Product Offered
13.15.3 RL Fine Chem Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 RL Fine Chem Main Business Overview
13.15.5 RL Fine Chem Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Telmisartan API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Telmisartan API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Purity ? 99%
Table 4. Major Players of Purity ? 99.5%
Table 5. Global Telmisartan API Sales by Type (2017-2022) & (Tons)
Table 6. Global Telmisartan API Sales Market Share by Type (2017-2022)
Table 7. Global Telmisartan API Revenue by Type (2017-2022) & ($ million)
Table 8. Global Telmisartan API Revenue Market Share by Type (2017-2022)
Table 9. Global Telmisartan API Sale Price by Type (2017-2022) & (US$/Ton)
Table 10. Global Telmisartan API Sales by Application (2017-2022) & (Tons)
Table 11. Global Telmisartan API Sales Market Share by Application (2017-2022)
Table 12. Global Telmisartan API Revenue by Application (2017-2022)
Table 13. Global Telmisartan API Revenue Market Share by Application (2017-2022)
Table 14. Global Telmisartan API Sale Price by Application (2017-2022) & (US$/Ton)
Table 15. Global Telmisartan API Sales by Company (2020-2022) & (Tons)
Table 16. Global Telmisartan API Sales Market Share by Company (2020-2022)
Table 17. Global Telmisartan API Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Telmisartan API Revenue Market Share by Company (2020-2022)
Table 19. Global Telmisartan API Sale Price by Company (2020-2022) & (US$/Ton)
Table 20. Key Manufacturers Telmisartan API Producing Area Distribution and Sales Area
Table 21. Players Telmisartan API Products Offered
Table 22. Telmisartan API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Telmisartan API Sales by Geographic Region (2017-2022) & (Tons)
Table 26. Global Telmisartan API Sales Market Share Geographic Region (2017-2022)
Table 27. Global Telmisartan API Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Telmisartan API Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Telmisartan API Sales by Country/Region (2017-2022) & (Tons)
Table 30. Global Telmisartan API Sales Market Share by Country/Region (2017-2022)
Table 31. Global Telmisartan API Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Telmisartan API Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Telmisartan API Sales by Country (2017-2022) & (Tons)
Table 34. Americas Telmisartan API Sales Market Share by Country (2017-2022)
Table 35. Americas Telmisartan API Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Telmisartan API Revenue Market Share by Country (2017-2022)
Table 37. Americas Telmisartan API Sales by Type (2017-2022) & (Tons)
Table 38. Americas Telmisartan API Sales Market Share by Type (2017-2022)
Table 39. Americas Telmisartan API Sales by Application (2017-2022) & (Tons)
Table 40. Americas Telmisartan API Sales Market Share by Application (2017-2022)
Table 41. APAC Telmisartan API Sales by Region (2017-2022) & (Tons)
Table 42. APAC Telmisartan API Sales Market Share by Region (2017-2022)
Table 43. APAC Telmisartan API Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Telmisartan API Revenue Market Share by Region (2017-2022)
Table 45. APAC Telmisartan API Sales by Type (2017-2022) & (Tons)
Table 46. APAC Telmisartan API Sales Market Share by Type (2017-2022)
Table 47. APAC Telmisartan API Sales by Application (2017-2022) & (Tons)
Table 48. APAC Telmisartan API Sales Market Share by Application (2017-2022)
Table 49. Europe Telmisartan API Sales by Country (2017-2022) & (Tons)
Table 50. Europe Telmisartan API Sales Market Share by Country (2017-2022)
Table 51. Europe Telmisartan API Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Telmisartan API Revenue Market Share by Country (2017-2022)
Table 53. Europe Telmisartan API Sales by Type (2017-2022) & (Tons)
Table 54. Europe Telmisartan API Sales Market Share by Type (2017-2022)
Table 55. Europe Telmisartan API Sales by Application (2017-2022) & (Tons)
Table 56. Europe Telmisartan API Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Telmisartan API Sales by Country (2017-2022) & (Tons)
Table 58. Middle East & Africa Telmisartan API Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Telmisartan API Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Telmisartan API Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Telmisartan API Sales by Type (2017-2022) & (Tons)
Table 62. Middle East & Africa Telmisartan API Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Telmisartan API Sales by Application (2017-2022) & (Tons)
Table 64. Middle East & Africa Telmisartan API Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Telmisartan API
Table 66. Key Market Challenges & Risks of Telmisartan API
Table 67. Key Industry Trends of Telmisartan API
Table 68. Telmisartan API Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Telmisartan API Distributors List
Table 71. Telmisartan API Customer List
Table 72. Global Telmisartan API Sales Forecast by Region (2023-2028) & (Tons)
Table 73. Global Telmisartan API Sales Market Forecast by Region
Table 74. Global Telmisartan API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Telmisartan API Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Telmisartan API Sales Forecast by Country (2023-2028) & (Tons)
Table 77. Americas Telmisartan API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Telmisartan API Sales Forecast by Region (2023-2028) & (Tons)
Table 79. APAC Telmisartan API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Telmisartan API Sales Forecast by Country (2023-2028) & (Tons)
Table 81. Europe Telmisartan API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Telmisartan API Sales Forecast by Country (2023-2028) & (Tons)
Table 83. Middle East & Africa Telmisartan API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Telmisartan API Sales Forecast by Type (2023-2028) & (Tons)
Table 85. Global Telmisartan API Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Telmisartan API Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Telmisartan API Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Telmisartan API Sales Forecast by Application (2023-2028) & (Tons)
Table 89. Global Telmisartan API Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Telmisartan API Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Telmisartan API Revenue Market Share Forecast by Application (2023-2028)
Table 92. Rundu Pharma Basic Information, Telmisartan API Manufacturing Base, Sales Area and Its Competitors
Table 93. Rundu Pharma Telmisartan API Product Offered
Table 94. Rundu Pharma Telmisartan API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 95. Rundu Pharma Main Business
Table 96. Rundu Pharma Latest Developments
Table 97. Jiangxi Synergy Pharmaceutical Basic Information, Telmisartan API Manufacturing Base, Sales Area and Its Competitors
Table 98. Jiangxi Synergy Pharmaceutical Telmisartan API Product Offered
Table 99. Jiangxi Synergy Pharmaceutical Telmisartan API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 100. Jiangxi Synergy Pharmaceutical Main Business
Table 101. Jiangxi Synergy Pharmaceutical Latest Developments
Table 102. Apeloa Pharmaceutical Basic Information, Telmisartan API Manufacturing Base, Sales Area and Its Competitors
Table 103. Apeloa Pharmaceutical Telmisartan API Product Offered
Table 104. Apeloa Pharmaceutical Telmisartan API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 105. Apeloa Pharmaceutical Main Business
Table 106. Apeloa Pharmaceutical Latest Developments
Table 107. Tianyu Pharmaceutical Basic Information, Telmisartan API Manufacturing Base, Sales Area and Its Competitors
Table 108. Tianyu Pharmaceutical Telmisartan API Product Offered
Table 109. Tianyu Pharmaceutical Telmisartan API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 110. Tianyu Pharmaceutical Main Business
Table 111. Tianyu Pharmaceutical Latest Developments
Table 112. Zhejiang Kinglyuan Pharmaceutical Basic Information, Telmisartan API Manufacturing Base, Sales Area and Its Competitors
Table 113. Zhejiang Kinglyuan Pharmaceutical Telmisartan API Product Offered
Table 114. Zhejiang Kinglyuan Pharmaceutical Telmisartan API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 115. Zhejiang Kinglyuan Pharmaceutical Main Business
Table 116. Zhejiang Kinglyuan Pharmaceutical Latest Developments
Table 117. Weightech (Hunan) Pharmaceutical Basic Information, Telmisartan API Manufacturing Base, Sales Area and Its Competitors
Table 118. Weightech (Hunan) Pharmaceutical Telmisartan API Product Offered
Table 119. Weightech (Hunan) Pharmaceutical Telmisartan API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 120. Weightech (Hunan) Pharmaceutical Main Business
Table 121. Weightech (Hunan) Pharmaceutical Latest Developments
Table 122. Liu He Pharmaceutical Basic Information, Telmisartan API Manufacturing Base, Sales Area and Its Competitors
Table 123. Liu He Pharmaceutical Telmisartan API Product Offered
Table 124. Liu He Pharmaceutical Telmisartan API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 125. Liu He Pharmaceutical Main Business
Table 126. Liu He Pharmaceutical Latest Developments
Table 127. Verdant Life Sciences Basic Information, Telmisartan API Manufacturing Base, Sales Area and Its Competitors
Table 128. Verdant Life Sciences Telmisartan API Product Offered
Table 129. Verdant Life Sciences Telmisartan API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 130. Verdant Life Sciences Main Business
Table 131. Verdant Life Sciences Latest Developments
Table 132. SMILAX Basic Information, Telmisartan API Manufacturing Base, Sales Area and Its Competitors
Table 133. SMILAX Telmisartan API Product Offered
Table 134. SMILAX Telmisartan API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 135. SMILAX Main Business
Table 136. SMILAX Latest Developments
Table 137. Cipla Basic Information, Telmisartan API Manufacturing Base, Sales Area and Its Competitors
Table 138. Cipla Telmisartan API Product Offered
Table 139. Cipla Telmisartan API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 140. Cipla Main Business
Table 141. Cipla Latest Developments
Table 142. Atom Pharma Basic Information, Telmisartan API Manufacturing Base, Sales Area and Its Competitors
Table 143. Atom Pharma Telmisartan API Product Offered
Table 144. Atom Pharma Telmisartan API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 145. Atom Pharma Main Business
Table 146. Atom Pharma Latest Developments
Table 147. Aalidhra Pharmachem Basic Information, Telmisartan API Manufacturing Base, Sales Area and Its Competitors
Table 148. Aalidhra Pharmachem Telmisartan API Product Offered
Table 149. Aalidhra Pharmachem Telmisartan API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 150. Aalidhra Pharmachem Main Business
Table 151. Aalidhra Pharmachem Latest Developments
Table 152. Dr. Reddy's Laboratories Basic Information, Telmisartan API Manufacturing Base, Sales Area and Its Competitors
Table 153. Dr. Reddy's Laboratories Telmisartan API Product Offered
Table 154. Dr. Reddy's Laboratories Telmisartan API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 155. Dr. Reddy's Laboratories Main Business
Table 156. Dr. Reddy's Laboratories Latest Developments
Table 157. InterQuim Basic Information, Telmisartan API Manufacturing Base, Sales Area and Its Competitors
Table 158. InterQuim Telmisartan API Product Offered
Table 159. InterQuim Telmisartan API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 160. InterQuim Main Business
Table 161. InterQuim Latest Developments
Table 162. RL Fine Chem Basic Information, Telmisartan API Manufacturing Base, Sales Area and Its Competitors
Table 163. RL Fine Chem Telmisartan API Product Offered
Table 164. RL Fine Chem Telmisartan API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 165. RL Fine Chem Main Business
Table 166. RL Fine Chem Latest Developments
List of Figures
Figure 1. Picture of Telmisartan API
Figure 2. Telmisartan API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Telmisartan API Sales Growth Rate 2017-2028 (Tons)
Figure 7. Global Telmisartan API Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Telmisartan API Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Purity ? 99%
Figure 10. Product Picture of Purity ? 99.5%
Figure 11. Global Telmisartan API Sales Market Share by Type in 2021
Figure 12. Global Telmisartan API Revenue Market Share by Type (2017-2022)
Figure 13. Telmisartan API Consumed in Tablet
Figure 14. Global Telmisartan API Market: Tablet (2017-2022) & (Tons)
Figure 15. Telmisartan API Consumed in Capsule
Figure 16. Global Telmisartan API Market: Capsule (2017-2022) & (Tons)
Figure 17. Telmisartan API Consumed in Other
Figure 18. Global Telmisartan API Market: Other (2017-2022) & (Tons)
Figure 19. Global Telmisartan API Sales Market Share by Application (2017-2022)
Figure 20. Global Telmisartan API Revenue Market Share by Application in 2021
Figure 21. Telmisartan API Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Telmisartan API Revenue Market Share by Company in 2021
Figure 23. Global Telmisartan API Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Telmisartan API Revenue Market Share by Geographic Region in 2021
Figure 25. Global Telmisartan API Sales Market Share by Region (2017-2022)
Figure 26. Global Telmisartan API Revenue Market Share by Country/Region in 2021
Figure 27. Americas Telmisartan API Sales 2017-2022 (Tons)
Figure 28. Americas Telmisartan API Revenue 2017-2022 ($ Millions)
Figure 29. APAC Telmisartan API Sales 2017-2022 (Tons)
Figure 30. APAC Telmisartan API Revenue 2017-2022 ($ Millions)
Figure 31. Europe Telmisartan API Sales 2017-2022 (Tons)
Figure 32. Europe Telmisartan API Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Telmisartan API Sales 2017-2022 (Tons)
Figure 34. Middle East & Africa Telmisartan API Revenue 2017-2022 ($ Millions)
Figure 35. Americas Telmisartan API Sales Market Share by Country in 2021
Figure 36. Americas Telmisartan API Revenue Market Share by Country in 2021
Figure 37. United States Telmisartan API Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Telmisartan API Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Telmisartan API Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Telmisartan API Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Telmisartan API Sales Market Share by Region in 2021
Figure 42. APAC Telmisartan API Revenue Market Share by Regions in 2021
Figure 43. China Telmisartan API Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Telmisartan API Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Telmisartan API Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Telmisartan API Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Telmisartan API Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Telmisartan API Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Telmisartan API Sales Market Share by Country in 2021
Figure 50. Europe Telmisartan API Revenue Market Share by Country in 2021
Figure 51. Germany Telmisartan API Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Telmisartan API Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Telmisartan API Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Telmisartan API Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Telmisartan API Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Telmisartan API Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Telmisartan API Revenue Market Share by Country in 2021
Figure 58. Egypt Telmisartan API Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Telmisartan API Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Telmisartan API Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Telmisartan API Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Telmisartan API Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Telmisartan API in 2021
Figure 64. Manufacturing Process Analysis of Telmisartan API
Figure 65. Industry Chain Structure of Telmisartan API
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Global Graphitized Carbon Black (GCB) Ma..
Graphitized carbon black is a black particle that can be use..
+16467917070US (Toll Free)